Innovate outlines filings for more than 60 new spectrum licenses while DBM holds $1.8B adjusted backlog (NYSE:VATE)
· seekingalpha.com
INNOVATE (VATE) Q1 2026 earnings call recap: revenue, adjusted EBITDA, $1.8B backlog, MediBeacon progress, Spectrum plans & debt risks—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...